PEDIATRICS Vol. 42 No. 5 November 1968, pp. 875
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mortimer, E. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mortimer, E. A., Jr.

Letters to the Editor

Edward A. Mortimer Jr. M.D.

Dr. Mortimer answers Dr. Greenblatt as follows:

You are probably aware that the Public Health Service Advisory Committee On Immunization Practices has recommended that influenza vaccine be given intradermally under only one circumstance, as a booster dose to older individuals who have previously experienced undue reactions to influenza vaccine.

You are correct in saying that there is not a satisfactory study of intradermal influenza vaccination in childhood. This is in part because such a study is extremely difficult to set up.